focus -WSS

focus

author：explore 2025-09-28 23:29:24 - browse：29336

Medical personnel wearing gloves adjust IV bags displayed on a conveyor belt. -- health policy coverage from STAT — Civica Rx is considering a move into chemotherapies amid drug shortages. Adobe

WASHINGTON — A nonprofit formed by hospitals to deal with drug shortages is considering a move into chemotherapies.

Frustrated by drug shortages and the price spikes that typically ensue, executives from large hospital systems launched the nonprofit Civica Rx to deal with the problem in September 2018. Months later, the publicly traded group purchasing organization Premier created a subsidiary, ProvideGx, with the same aim.

Although shortages are not new, the number of drugs in short supply has grown steadily for about two years. Shortages also have become more difficult to predict and are affecting drugs that are more critical.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Lawsuit challenges CMS nursing home minimum staffing rule

leisure time

WSS

Some medical students still think black patients feel less pain

New research sheds light on how often breast cancer is overdiagnosed

The future of Biogen: Pragmatism, ‘moonshots,’ and no Twinkies

Why a market frenzy over new weight loss drugs defies logic

ADCs take center stage as promising cancer treatments

Cassava Sciences’ Alzheimer’s clinical trials should be halted

focus

focus

focus

Duchenne breakthrough therapy leaves behind pioneering families

Protect nursing home residents from future pandemics

United colonoscopy coverage change 'may cost lives,' doctors say

Beyond aggravation: Constipation is an American epidemic

Continuity nursing helped my family in our darkest PICU moments

Readout LOUD podcast: Live from the 2023 STAT Summit

Cancer drug shortages should be causing more outrage

How AI can help patients find reliable information about doctors

BioMarin wins approval for gene therapy to treat hemophilia A

The future of Biogen: Pragmatism, ‘moonshots,’ and no Twinkies

hotspot

Health tech investors get more selective as pandemic boom fades

STAT Readout: Friday, Oct. 20 biotech updates

Asahi Kasei to buy Calliditas, picking up kidney disease drug

Ozempic cut risk of death in diabetes patients with chronic kidney disease

U.S. death rates show how politics are affecting public health

Bird flu makes raw milk dangerous to consume, mouse study finds

focus

leisure time

focus

hotspot